Cargando…
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Dendritic cells (DCs) have shown great potential as a component or target in the landscape of cancer immunotherapy. Different in vivo and ex vivo strategies of DC vaccine generation with different outcomes have been proposed. Numerous clinical trials have demonstrated their efficacy and safety in ca...
Autores principales: | Baldin, Alexey V., Savvateeva, Lyudmila V., Bazhin, Alexandr V., Zamyatnin, Andrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139354/ https://www.ncbi.nlm.nih.gov/pubmed/32150821 http://dx.doi.org/10.3390/cancers12030590 |
Ejemplares similares
-
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
por: Abakushina, Elena V., et al.
Publicado: (2021) -
Cancer Vaccines: Antigen Selection Strategy
por: Zhao, Yue, et al.
Publicado: (2021) -
mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
por: Bidram, Maryam, et al.
Publicado: (2021) -
Nanomedicine for increasing the oral bioavailability of cancer treatments
por: Parodi, Alessandro, et al.
Publicado: (2021) -
Structure determinants defining the specificity of papain-like cysteine proteases
por: Petushkova, Anastasiia I., et al.
Publicado: (2022)